These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32767509)

  • 1. Association of killer-cell immunoglobulin-like receptor genes with acute myelogenous leukaemia.
    Alavianmehr A; Mansouri M; Ramzi M; Faghih M; Monabati A; Arandi N; Faghih Z; Farjadian S
    Int J Immunogenet; 2020 Dec; 47(6):512-521. PubMed ID: 32767509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
    Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
    Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians.
    Barani S; Khademi B; Ashouri E; Ghaderi A
    Hum Immunol; 2018 Apr; 79(4):218-223. PubMed ID: 29408295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
    Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
    Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive association of Bx genotype, KIR2L5, KIR2DS5 and full-length KIR2DS4 with the risk of meningioma.
    Barani S; Taghipour M; Ghaderi A
    Immunobiology; 2020 Mar; 225(2):151900. PubMed ID: 31899050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.
    Taniguchi M; Kawabata M
    Immunogenetics; 2009 Dec; 61(11-12):717-30. PubMed ID: 19859704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating KIR/HLA-I combinations as a risk factor of adult B-ALL.
    Halimi H; Mirzazadeh S; Kalantar K; Hajimaghsoodi M; Ramzi M; Farjadian S
    Hum Immunol; 2024 Mar; 85(2):110750. PubMed ID: 38262874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.
    Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C
    Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of KIR gene expression at the mRNA level in specific donor-derived NK cells after allogeneic HSCT.
    Li Y; Wang T; Hu X; Zhang H; Chen L; Bao X; He J
    Immunogenetics; 2020 Apr; 72(3):135-141. PubMed ID: 31900503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis.
    Harvey D; Pointon JJ; Sleator C; Meenagh A; Farrar C; Sun JY; Senitzer D; Middleton D; Brown MA; Wordsworth BP
    Ann Rheum Dis; 2009 Apr; 68(4):595-8. PubMed ID: 19019897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating and inhibitory killer cell immunoglobulin like receptors (KIR) genes are involved in an increased susceptibility to colorectal adenocarcinoma and protection against invasion and metastasis.
    Barani S; Hosseini SV; Ghaderi A
    Immunobiology; 2019 Sep; 224(5):681-686. PubMed ID: 31248612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
    Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
    Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
    Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
    Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
    Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR2DS3 is associated with protection against acute myeloid leukemia.
    Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
    Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved KIR gene and HLA-C KIR ligand sequence-specific primer polymerase chain reaction genotyping using whole genome amplification.
    Chainonthee W; Böttcher G; Gagne K; Füssel M; Bignon JD; Wassmuth R
    Tissue Antigens; 2010 Aug; 76(2):135-43. PubMed ID: 20403144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of killer cell immunoglobulin-like receptors in the Greek population.
    Niokou D; Spyropoulou-Vlachou M; Darlamitsou A; Stavropoulos-Giokas C
    Hum Immunol; 2003 Dec; 64(12):1167-76. PubMed ID: 14630399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.